You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 1 No. 1, July 1959 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (12)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Comparison of the LSD-25 Experience and Delirium Tremens

KEITH S. DITMAN, M.D.; JOHN R. B. WHITTLESEY, M.S.

AMA Arch Gen Psychiatry 1959;1(1):47-57.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Recently psychiatry has had a renewed interest in drugs with "hallucinogenic" properties. New ones are being made, or extracted from plants, at a rapid rate. These drugs are being used more and more widely in treatment and in psychodynamic investigations. We are struck by the many claims that have been made about these psychopharmacological agents and, in particular, have noted the varied and often contradictory descriptions of their psychic effects—effects which have been labeled "experimental schizophrenia," "model psychosis," "toxic delirium," and so on. In this paper our interest in lysergic acid diethylamide, or LSD-25, is not particularly in its value in psychotherapy, or with its use as an agent for investigation of psychodynamics. Rather, our interest is in developing an objective method for studying the subjective aspects of these experiences. We have sought a method which would not interfere with the experience, . . . [Full Text PDF of this Article]


Author Affiliations

Los Angeles


Footnotes

Submitted for publication Aug. 22, 1958.

Lysergic acid diethylamide (LSD-25) was supplied by Mr. Harry Althouse, of Sandoz, Inc., San Francisco.

Read before the 114th Annual meeting of the American Psychiatric Association, San Francisco, May 16, 1958.

Alcoholism Research Clinic, Department of Psychiatry, University of California at Los Angeles Medical Center.

This research was supported by a grant from the Division of Alcoholic Rehabilitation, State of California Department of Public Health.

The computations involved were made with the assistance of the IBM facilities of the Western Data Processing Center, Graduate School of Business Administration, University of California at Los Angeles.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1959 American Medical Association. All Rights Reserved.